Amgen AMGN Total costs & expenses

Total costs & expenses at other companies

Regeneron PharmaceuticalsREGN

$3B+15.5%

Nektar TherapeuticsNKTR

$49.92M-9.2%

Rigel PharmaceuticalsRIGL

$46.93M+15.7%

Jazz PharmaceuticalsJAZZ

$732.3M-23.2%

Cogent Biosciences, Inc.COGT

$103.61M+38.3%

AbbVieABBV

——

FAQ

What is Amgen's total costs & expenses?

Amgen (AMGN) reported total costs & expenses of $6.54B in Q2 2026.

How has Amgen's total costs & expenses changed year-over-year?

Amgen's total costs & expenses increased by 0.3% year-over-year, from $6.52B to $6.54B.

What is the long-term trend for Amgen's total costs & expenses?

Over 4 years (2021 to 2025), Amgen's total costs & expenses has grown at a 10.8% compound annual growth rate (CAGR), from $18.34B to $27.67B.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue during a specific period. It encompasses cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure allows investors to assess the company's overall cost structure and operational efficiency in supporting its commercial activities.